关注
Dr Trudi Collet PhD
Dr Trudi Collet PhD
Leader - Innovative Medicines Group (IMG)
在 qut.edu.au 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases
M Mehta, D Tewari, G Gupta, R Awasthi, H Singh, P Pandey, ...
Chemico-biological interactions 308, 206-215, 2019
7582019
The potential of siRNA based drug delivery in respiratory disorders: Recent advances and progress
K Dua, R Wadhwa, G Singhvi, V Rapalli, SD Shukla, MD Shastri, G Gupta, ...
Drug development research 80 (6), 714-730, 2019
5432019
Increasing complexity and interactions of oxidative stress in chronic respiratory diseases: an emerging need for novel drug delivery systems
K Dua, V Malyla, G Singhvi, R Wadhwa, RV Krishna, SD Shukla, ...
Chemico-biological interactions 299, 168-178, 2019
1222019
Knowledge management research in the construction industry: a review
D Yu, J Yang
Journal of the Knowledge Economy 9, 782-803, 2018
98*2018
Interactions with the macrophages: an emerging targeted approach using novel drug delivery systems in respiratory diseases
M Mehta, N Sharma, M Vyas, N Khurana, PK Maurya, H Singh, ...
Chemico-biological interactions 304, 10-19, 2019
972019
Leptospirosis from water sources
SJ Wynwood, GC Graham, SL Weier, TA Collet, DB McKay, SB Craig
Pathogens and Global Health 108 (7), 334-338, 2014
922014
Molecular modulators of celastrol as the keystones for its diverse pharmacological activities
SW Ng, Y Chan, DK Chellappan, T Madheswaran, F Zeeshan, YL Chan, ...
Biomedicine & Pharmacotherapy 109, 1785-1792, 2019
862019
Recent advances in DNA gyrase-targeted antimicrobial agents
SN Dighe, TA Collet
European Journal of Medicinal Chemistry 199, 112326, 2020
762020
Recent update on anti-dengue drug discovery
SN Dighe, K Dua, DK Chellappan, PL Katavic, TA Collet
European journal of medicinal chemistry 176, 431-455, 2019
652019
MicroRNAs as biomarker for breast cancer
T Aggarwal, R Wadhwa, R Gupta, KR Paudel, T Collet, DK Chellappan, ...
Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2020
582020
Identification of biomarkers and genetic approaches toward chronic obstructive pulmonary disease
R Wadhwa, T Aggarwal, V Malyla, N Kumar, G Gupta, DK Chellappan, ...
Journal of cellular physiology 234 (10), 16703-16723, 2019
402019
Interactions between microbiome and lungs: Paving new paths for microbiome based bio-engineered drug delivery systems in chronic respiratory diseases
DK Chellappan, QLS Ning, SKS Min, SY Bin, PJ Chern, TP Shi, SWE Mei, ...
Chemico-biological interactions 310, 108732, 2019
402019
Applications of nanocarriers as drug delivery vehicles for active phytoconstituents
PQ Ng, LSC Ling, J Chellian, T Madheswaran, J Panneerselvam, ...
Current pharmaceutical design 26 (36), 4580-4590, 2020
392020
Nanoparticle-based drug delivery for chronic obstructive pulmonary disorder and asthma: Progress and challenges
R Wadhwa, T Aggarwal, N Thapliyal, DK Chellappan, G Gupta, M Gulati, ...
Nanotechnology in modern animal biotechnology, 59-73, 2019
292019
Molecular and immunological mechanisms underlying the various pharmacological properties of the potent bioflavonoid, rutin
DOC Yong, SR Saker, DK Chellappan, T Madheswaran, ...
Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2020
282020
Obesity and diabetes: pathophysiology of obesity-induced hyperglycemia and insulin resistance
G Gupta, R Wadhwa, P Pandey, SK Singh, M Gulati, S Sajita, M Mehta, ...
Pathophysiology of obesity-induced health complications, 81-97, 2020
272020
Emerging complexity and the need for advanced drug delivery in targeting Candida species
R Wadhwa, P Pandey, G Gupta, T Aggarwal, N Kumar, M Mehta, S Satija, ...
Current topics in medicinal chemistry 19 (28), 2593-2609, 2019
272019
Current status on immunological therapies for type 1 diabetes mellitus
GLL Xin, YP Khee, TY Ying, J Chellian, G Gupta, AP Kunnath, S Nammi, ...
Current diabetes reports 19, 1-10, 2019
272019
The emergence of Leptospira borgpetersenii serovar Arborea as the dominant infecting serovar following the summer of natural disasters in Queensland, Australia 2011
S Wynwood, S Craig, G Graham, B Blair, MA Burns, S Weier, T Collet, ...
Tropical biomedicine 31 (2), 281-285, 2014
262014
Harnessing the therapeutic potential of fisetin and its nanoparticles: Journey so far and road ahead
S Vishwas, SK Singh, M Gulati, A Awasthi, R Khursheed, L Corrie, ...
Chemico-Biological Interactions 356, 109869, 2022
222022
系统目前无法执行此操作,请稍后再试。
文章 1–20